Biopharma Informatic
Generated 5/10/2026
Executive Summary
Biopharma Informatic is a clinical research investigator network and services company that bridges the gap between pharmaceutical sponsors/CROs and investigative sites. With over 100 investigators across 30+ active sites, it provides a turnkey solution for physician offices to conduct clinical trials, covering business development, study startup, patient enrollment, and closeout. The company leverages AI and machine learning to optimize patient recruitment and site selection, addressing key bottlenecks in drug development. Founded in 2018 and headquartered in San Diego, Biopharma Informatic capitalizes on the growing trend toward decentralized and site-centric trials, offering sponsors faster access to diverse patient populations and experienced investigators. As the clinical trial landscape becomes more complex and cost-sensitive, the company's technology-enabled network positions it as a valuable partner for streamlining trial operations. Its focus on specialized therapeutic fields further differentiates it from broader CROs. However, as a private service company, its growth is tied to the volume of trials and partnerships it secures. The increasing adoption of AI in clinical research and the need for efficient patient recruitment present significant opportunities for Biopharma Informatic to expand its network and revenue. Future success will depend on its ability to scale operations, maintain high-quality outcomes, and secure contracts with top pharmaceutical sponsors.
Upcoming Catalysts (preview)
- TBDMajor partnership with a top-20 pharmaceutical company for multi-site trial40% success
- Q4 2026Expansion of investigator network to 200+ sites and 500+ investigators55% success
- Q2 2026Launch of AI-driven patient recruitment platform with demonstrated ROI60% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)